Bioactivity | NGR peptide Trifluoroacetatecontaining the Asn-Gly-Arg (NGR) motif. NGR peptide Trifluoroacetate binds to APN/CD13. NGR peptide Trifluoroacetate is directly conjugated to imaging agents that can be used for tumor imaging[1][2]. | ||||||
In Vivo | NGR peptide Trifluoroacetate (20 mg/kg; i.v.) 可用作肿瘤成像和早期诊断的潜在 SPECT 试剂[2]。 Animal Model: | ||||||
Name | NGR peptide Trifluoroacetate | ||||||
Sequence | Cys-Asn-Gly-Arg-Cys-Gly | ||||||
Shortening | CNGRCG | ||||||
Formula | C22H37F3N10O10S2 | ||||||
Molar Mass | 722.72 | ||||||
Appearance | Solid | ||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||
Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
Reference | [1]. Wang RE, et al. Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging. 2011;1(1):36-46. [2]. Ma W, et al. Biodistribution and SPECT imaging study of (99m)Tc labeling NGR peptide in nude mice bearing human HepG2 hepatoma. Biomed Res Int. 2014;2014:618096. |